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Exposure of chloroplast F1 ATPase to 2-azido-ATP results in the noncovalent ight binding of 2-azido-ATP 
or 2-azido-ADP to noncatalytic or to catalytic sites. Subsequent photolysis results in covalent labeling of 
adjacent tryptic peptides of the &subunit. Binding at noncatalytic sites results in labeling of tyrosine 385 
by an ATP or an ADP moiety. Binding at catalytic sites results in labeling of tyrosine 362 by only an ADP 
moiety. Similar labeling patterns are observed for the heat-activated or the membrane-bound enzymes. 
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1. INTRODUCTION 
The F1 component of the chloroplast ATP syn- 
thase (CFI) has an C&Q& subunit composition. 
Nucleotide binding sites with several different 
characteristics have been described. A prominent 
view has been that only 3 nucleotide binding sites 
are present on CFI, and evidence has been ob- 
tained that both catalytic and noncatalytic sites can 
bind ADP or ATP tightly (reviews [l-3]). Such 
findings were difficult to reconcile with the binding 
change mechanism with sequential participation of 
three catalytic sites. Some clarification has come 
from recent evidence that the CFl, like the 
mitochondrial (MFI) [4] and E. cofi (EFI) [5] en- 
zymes, has six potential nucleotide binding sites, 
and that 2-azido-adenine nucleotides can derivatize 
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separate catalytic and noncatalytic sites on the p- 
subunits [6]. 
2-Azido ATP and 2-azido ADP (2-azido-ANP), 
like ATP and ADP, can bind tightly to CFI and 
give covalent derivatization with high yield [6,7]. 
We report here that the azido analogs, when bound 
at catalytic and noncatalytic sites of CF1, efficient- 
ly label two adjacent tryptic peptides on the & 
subunit. Both peptides are derivatized on conserv- 
ed tyrosine residues. 
2. MATERIALS AND METHODS 
The 2-azido-ANP was prepared as described [S], 
and the 2-azido ADP and ATP were purified on a 
Bio-Rad AG MP-1 anion-exchange column. In- 
cubations of CF1 with azido nucleotides were in 
40 mM Tricine (pH 7.8) at room temperature. 
After passage through Sephadex-centrifuge col- 
umns the CFI was exposed to ultraviolet light 
(‘Mineralite’ lamp) in a flat plastic vessel 1.5 cm 
from the lamp for 50 min. The long exposure to 
low intensity light allows the conversion of the 
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bound tetrazole forms [9] to the azido form. The 
protein was precipitated in 0.5 M perchloric acid, 
washed with 80% acetone, and resuspended in 
0.1 M NH4HCO3 (pH 8); trypsin was added (l/40 
of the weight of CF1) and the sample incubated at 
room temperature overnight. Ion-exchange and 
reverse-phase HPLC separations were performed 
as described in [lo]. 
3. RESULTS 
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3.1. Derivatization and separation of tryptic 
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When latent CFI is incubated with 2-azido-ATP, 
at least 4 azido nucleotides become tightly bound 
[6,8]. Fig.1 shows a typical separation on the 
anion-exchange HPLC column of tryptic peptides 
obtained from latent CFI sample modified with 
2-azido-p,r-32P]ATP under conditions that label 
both catalytic and noncatalytic sites. Hydrolysis of 
the 2-azido-ATP allows derivatization by both an 
ADP and an ATP moiety. Most of the unlabeled 
tryptic peptides are not retained or are eluted early. 
The peptides modified with an ADP moiety are 
eluted later in the same region as free ADP (about 
31 min, 28% solvent B), and those modified with 
an ATP moiety before free ATP (44 min, 54% sol- 
vent B). The ratios of A215 to 32P present indicate 
that more underivatized peptides remain in the 
ADP-peptide fraction than in the ATP-peptide 
fraction. The recovery of modified peptides, based 
on the 32P present, is about 85%. As reported 
earlier [6], no labeling of a-subunit is detected (not 
shown). 
Fig.1. The separation of ADP- and ATP-labeled 
peptides on an ion-exchange HPLC column. Latent CF1 
(5 mg in 1 ml) was exposed to 200,~M 2-azido- 
p,y3’P]ATP and 1 mM Mg2+ for 10 min, then treated 
as described in section 2. Presence of 32P is indicated by 
cross-hatching. 
(table l), showed that the first peptide was 
modified at Tyr-385 and the second at Tyr-362. 
The ATP-peptide fraction from the ion- 
exchange column gave only a single peak eluting at 
15% solvent B (fig.2B). Its retention time on the CS 
column was close to that of the ADP-modified 
peptides that eluted first, suggesting that the pep- 
tides had the same composition. This was con- 
firmed by sequencing of the ATP-peptide. 
3.3. Correlation of labeling with catalytic or 
noncatalytic site occupancy 
3.2. Purification of peptides by reversed-phase 
HPLC and sequence analysis 
The fractions from the ion-exchange column 
were concentrated by lyophilization and further 
purified on the CS column. The ADP-peptide frac- 
tion yielded two radioactive peaks at 15% solvent 
B (29 min) and at 25% (39 min) with high absorp- 
tion at 260 nm relative to unlabeled peptides 
(fig.2A). The recovery of labeled peptides for such 
HPLC separations is about 90% when 500 pmol or 
more of the peptides are loaded. 
The nature of the enzyme sites to which the 
nucleotide moieties are attached is readily shown 
by experiments using different labeling conditions. 
The second peak (39 min, ADP-fraction, fig.2) 
can be largely eliminated by a short chase with 
ATP before Sephadex column separation and UV 
irradiation [6]. The peptide is from a portion of the 
P-subunit that is highly conserved in the enzyme 
from different sources [ 111, that is derivatized by 
2-azido-ANP in EFl [lo] and in MFr [12,13] and 
for which the derivatization has been shown to 
arise from catalytic site binding in MFr [13] and 
EFi [lo]. 
Each ADP-peptide peak (fig.2A) consisted of a The first peak (29 min, ATP fraction, fig.2) is 
single peptide modified at a single position. The se- not diminished by a short ATP chase, pointing to 
quences obtained, and the lack of expected a noncatalytic site location for the derivatizing 
tyrosine residues [l l] in their respective cycles 2-azido-ATP. Sequence data (table 1) show 
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Fig.2. (A) Purification on a reversed-phase C8 HPLC 
column of ADP-derivatized tryptic peptides from first- 
labeled peak of fig.1. Presence of 32P is indicated by 
cross-hatching. (B) Similar data for the ATP-derivatized 
peptide of fig.1. 
modification of Tyr-385 in a tryptic peptide adja- 
cent to that for the catalytic site peptide. Again, 
the peptide is from a conserved region of the ,& 
subunit, and corresponds to the similar peptide 
labeled by 2-azido-ANP at the noncatalytic site of 
MFr [ 131 and EFr [lo]. This homology strengthens 
the identification of the ATP-labeling site on CFr 
as noncatalytic. 
The noncatalytic site location is also cor- 
roborated by tests based on the tight MgATP 
binding site on CFr demonstrated in Hammes’ 
laboratory [3,14] and regarded as a noncatalytic 
site. When this site is filled by Mg-2-azido-ATP in 
heat-activated CFr, using the conditions described 
[14], only an ATP-peptide, migrating at the same 
retention time as the first peak (fig.2) is obtained. 
In this and other experiments, the same peptide 
labeling patterns for catalytic and noncatalytic site 
binding were obtained when the azido nucleotides 
were bound to heat-activated CFr or to membrane- 
bound CFr and the same sequences demonstrated 
for the heat-activated CFr (not shown). 
Our results show that exposure to 2-azido-ATP 
Table 1 
Microsequence analysis of 2-N3-ANP modified peptides 
Cycle PTH-amino acid residue (pmol) 
Catalytic peptide Noncatalytic peptide 
1 Gly (40) Ile (24) 
2 Be (30) Val (72) 
3 _ Gly (16) 
4 Pro (19) Glu (28) 
5 Ala (36) Glu (42) 
6 Val (35) His (5) 
7 Asp (25) - 
8 Pro (10) Glu (18) 
9 Leu (22) Be (50) 
10 Asp (18) Ala (12) 
11 Ser (5) Gln (24) 
12 Thr (7) Arg (3) 
13 Ser (5) 
14 Thr (7) 
15 Met (6) 
16 Leu (8) 
17 Gln (2) 
18 Pro (2) 
19 Arg (2 ) 
HPLC purified peptides were subjected to automated 
Edman degradations on a City of Hope-built gas-phase 
microsequencer as described elsewhere [131. A dash ( - ) 
indicates that no quantifiable PTH-derivative was 
present 
leads to catalytic site labeling only by an ADP 
moiety. This is true even if pyruvate kinase and 
phosphoenolpyruvate are present to remove 
2-azido-ADP and with the latent enzyme that has 
very weak hydrolytic capacity. Probably any 
bound 2-azido-ATP is hydrolyzed to bound 
2-azido-ADP before or perhaps even after covalent 
insertion. Whenever a covalently bound ATP 
moiety has been found in our studies, it has been 
associated with the noncatalytic site. The non- 
catalytic site can also be occupied by ADP as 
shown in section 3.2. 
Comment may be appropriate that the iden- 
tification of the nucleotide in the fractions 
designated as ADP- or ATP-peptides is based on: 
(i) the expected insertion of the bound nucleotide 
without decomposition; (ii) the migration in the 
ion-exchange separation as shown in fig. 1, which 
shows the same sequence for the peptides labeled 
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at noncatalytic sites with an ADP or an ATP moie- 
ty and thus that the migration differences did not 
result from differences in peptide composition; (iii) 
the separation of &subunits in isoelectric focusing 
SDS gels which shows the expected added charge 
for derivatization with either an ADP or an ATP 
moiety [6]; (iv) the relative ratio of 32P to protein 
after separation in 2-dimensional gels with labeling 
by 2-azido-v,y-32P]ATP or 2-azido-~-32P]ADP 
[6]; and (v) the ratios of 32P in azido-nucleotides 
noncovalently but tightly bound prior to 
photolysis to the amount of [3H]ADP or [3H]ATP 
bound under similar conditions. 
4. DISCUSSION 
Our results allow identification of separate 
catalytic and noncatalytic binding sites on CFr. 
Although only labeling of the P-subunit is ob- 
served, one or both sites could be at cu-P-subunit 
interfaces with orientation of the nitrene formed 
from the 2-azido group towards the &subunit. 
Previously Abbott et al. [7] showed that tightly 
bound 2-azido-ADP and 2-azido-ATP on 
chloroplast thylakoid membranes labeled the P- 
subunit of CFr. Whether both catalytic and non- 
catalytic sites were labeled under the experimental 
conditions used by Abbott et al. [7] remains to be 
evaluated. The derivatization of Tyr-362 by 
2-azido-ADP is the same as that very recently 
reported by Adman and Hammes [15] for labeling 
with 2 ’ ,3 ’ -0-(4benzoyl)benzoyl-ADP [ 151. Based 
on results reported here, their labeling probably 
occurred at a catalytic site. They did not identify a 
separate noncatalytic site derivatization. 
The observations that the same labeled peptides 
are obtained from the latent CFr, the membrane- 
bound CFr, or the heat-activated CFr have impor- 
tant implications. Separation of the enzyme from 
the membrane or heat activation- apparently does 
not change the binding orientations at the catalytic 
site. Because the latent enzyme with 2-azido-ANP 
bound at three noncatalytic sites yields only one 
uniquely labeled noncatalytic peptide the confor- 
mations of all three noncatalytic binding sites are 
likely similar. This is of interest because only one 
tight MgATP noncatalytic site is readily observed 
with the CFr as usually prepared [14]. 
We are currently applying the procedures 
described in this communication to help clarify 
questions that have been raised about the location 
and function of nucleotide binding sites of the 
CF,. 
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